The U.S. State Department on Tuesday moved to block 13 people from entering the United States, zeroing in on an India-based operation accused of shipping counterfeit, fentanyl-laced pills to American buyers. The visa action lands alongside sanctions and criminal prosecutions aimed at choking off online pharmacies and transnational suppliers that investigators say have worsened the overdose crisis.
The restrictions were first reported by the Tampa Free Press, which said the move targets associates of KS International Traders and quoted the State Department as saying, "Those complicit in poisoning Americans will be denied entry to the United States." The outlet also noted that the names of the 13 individuals were not immediately released.
Targets Tied to KS International Traders
In September 2025 the U.S. Department of the Treasury’s Office of Foreign Assets Control designated two Indian nationals and KS International Traders, accusing them of supplying hundreds of thousands of counterfeit pills laced with fentanyl to victims across the country, according to the U.S. Department of the Treasury. The action placed those parties on the Specially Designated Nationals list and warned U.S. banks and businesses against transacting with the network.
Prosecutions and the Unsealed Indictment
Federal prosecutors in Manhattan unsealed charges in September 2024 against a transnational network that allegedly manufactured and shipped millions of counterfeit pills through fake online pharmacies, linking the operation to pill-pressing labs in New York, according to a U.S. Attorney’s Office for the Southern District of New York press release. The indictment described at least nine overdose deaths tied to pills sold through the network and named defendants based in the United States, the Dominican Republic and India.
A New Policy Backdrop
The visa move arrives in the middle of a broader policy shift in which the administration has begun treating illicit fentanyl and its precursors as a national security threat, including an executive order that designates those substances as a "weapon of mass destruction," according to the White House. That designation is meant to unlock additional tools such as financial measures, sanctions and immigration restrictions that officials say can be used together to disrupt supply chains and the people who enable them.
What Enforcement Agencies Have Warned
The Drug Enforcement Administration has repeatedly warned that deceptive foreign online pharmacies, including some operating out of India and the Dominican Republic, are selling counterfeit pills that may contain fentanyl or methamphetamine, in a public safety alert the agency issued in October 2024. The Centers for Disease Control and Prevention has noted that synthetic opioids such as fentanyl have been the primary driver of U.S. overdose deaths in recent years, a backdrop that helps explain why officials are aiming their enforcement tools at the overseas source as well as domestic distributors.
Legal Implications
The Tampa Free Press reported that the visa restrictions were issued under the Immigration and Nationality Act, a mechanism the State Department can use to make certain foreign nationals inadmissible. Economic designations under E.O. 14059 and OFAC listings can freeze U.S.-based assets and expose banks or businesses to penalties for dealing with designated parties, and the criminal charges unsealed in the Southern District of New York carry severe penalties if defendants are convicted in federal court.
For now, the administration appears to be leaning on a three-pronged strategy of immigration restrictions, sanctions and criminal prosecutions to raise the cost of doing business for international suppliers and the platforms that help them appear legitimate. Officials say coordinated steps with foreign partners will determine whether additional names or measures are announced publicly in the coming days.
